Literature DB >> 16253906

Prolongation of the fast pathway effective refractory period during cryoablation in children: a marker of slow pathway modification.

Aya Miyazaki1, Andrew D Blaufox, David L Fairbrother, J Philip Saul.   

Abstract

BACKGROUND: The fast pathway effective refractory period (ERP) has been reported to decrease after slow pathway modification with radiofrequency (RF) energy. How the fast pathway ERP changes during the ablation application has not been reported with either RF or cryoenergy.
OBJECTIVES: Using the unique features of cryotherapy, this study assesses the short-term changes in fast pathway ERP during cryomodification of the slow pathway and examines whether these changes are a useful marker for successful slow pathway modification in children.
METHODS: Nineteen pediatric patients (median age 15.1 years, range 9.6-19.6 years; weight 60.7 kg, range 35.6-130.2 kg) with anterograde dual AV nodal physiology underwent slow pathway modification with catheter-based cryoablation. Programmed stimulation was performed during cryoapplications after reaching -25 degrees C to assess fast pathway and slow pathway conduction. Data were analyzed from 59 of 237 cryoapplications where the fast pathway ERP was measured more than once (n = 13 patients).
RESULTS: For 23 of 59 applications where the slow pathway was modified, the fast pathway ERP significantly increased during cryotherapy (Delta = 33.5 ms, P <.0001). The magnitude of fast pathway ERP prolongation during cryotherapy was larger when the slow pathway was modified than when there was no effect on slow pathway conduction (33.5 +/- 30.5 vs 5.8 +/- 18.9 ms, P =.0005). Prolongation of fast pathway ERP by >/=20 ms had 70% sensitivity and 72% specificity for predicting slow pathway modification. Following termination of cryoapplications, which resulted in slow pathway modification, the fast pathway ERP had significantly decreased from baseline (difference 44.5 ms, P <.0001). The effect on fast pathway ERP was not related to changes in cycle length during (R(2) = 0.04, P = .045) or after ablation (R(2) = 0.13, P = .012).
CONCLUSION: The fast pathway ERP prolongs during cryoapplications that result in slow pathway modification and shortens after termination of cryoapplications. The magnitude of fast pathway ERP prolongation during cryoapplication may be useful as a marker for successful slow pathway modification.

Entities:  

Mesh:

Year:  2005        PMID: 16253906     DOI: 10.1016/j.hrthm.2005.08.017

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  3 in total

1.  Cryoablation therapy for atrioventricular nodal reentrant tachycardia in children: a multicenter experience of efficacy.

Authors:  Srikant Das; Ian H Law; Nicholas H Von Bergen; David J Bradley; Macdonald Dick; Susan P Etheridge; Elizabeth V Saarel; Patricio A Frias; Margaret J Strieper; Peter S Fischbach
Journal:  Pediatr Cardiol       Date:  2012-03-20       Impact factor: 1.655

2.  Permanent and Transient Electrophysiological Effects During Cardiac Cryoablation Documented by Optical Activation Mapping and Thermal Imaging.

Authors:  Greg Morley; Scott Bernstein; Laura Kuznekoff; Carolina Vasquez; Phil Saul; Dieter Haemmerich
Journal:  IEEE Trans Biomed Eng       Date:  2018-11-09       Impact factor: 4.538

3.  Cryoablation for atrioventricular nodal reentrant tachycardia in young patients: predictors of recurrence.

Authors:  Nikhil K Chanani; Nancy A Chiesa; Anne M Dubin; Kishor Avasarala; George F Van Hare; Kathryn K Collins
Journal:  Pacing Clin Electrophysiol       Date:  2008-09       Impact factor: 1.976

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.